§ 672.314; Ga. Code. Defendants simply ignored these regulations and, disregarding the scientific evidence available to them, did not report to the FDA significant new information affecting the safety or labeling of Zantac. 182. To the extent applicable, each Defendant intended, knew, had reason to know, recklessly disregarded, or should have known that its fraudulent and deceptive acts, omissions, or concealment would induce reliance, or reliance can be presumed in the circumstances.

Ann.

The study's authors noted that for those participants who took either cimetidine or 62 Id.

49 GlaxoSmithKline –Product Portfolio, PHARMACEUTICALS COMPANY ANALYSIS (Jan. 21, 2003). You need to contact a lawyer licensed in your jurisdiction for advice on specific legal issues problems.We will evaluate your claim and determine if you are owed money for the injuries and health complications associated with taking Zantac (ranitidine) Zantac was approved for prescription use by the FDA in 1983. at 252. at 7. ; c. Defendants have engaged in unfair competition or unfair or deceptive acts or practices in violation of Arizona Rev. In addition to causing cancer, ranitidine can also produce a several unwanted side effects. 107. "29 28 BLOOMBERG LAW, Carcinogen in Zantac and Generics Triggers FDA, EU Probes (2) (Sept. 13, 2019), available at https://news.bloomberglaw.com/health-law-and-business/fda-eu-probing- carcinogen-detected-in-versions-of-zantac-1 (last accessed Nov. 11, 2019). at 632-33. Since the FDA approved Zantac in the 1980s, numerous studies have shown The four products affected are Zantac 150mg/10ml Syrup, Zantac 50mg/2ml Injection, Zantac 150mg Tablets and Zantac 300mg Tablets.

Glaxo Labs (now GlaxoSmithKline plc) also conducted the clinical trials and other trials associated with the New Drug Application (NDA 18703) it submitted to the FDA for Zantac. Ex. Pursuant to 28 USC 636(c), the parties are hereby notified that the U.S. Magistrate Judge Alicia M. Otazo-Reyes is available to handle any or all proceedings in this case. 2924 Document Document 1-4 Entered 13-3 Filed on FLSD 11/12/19 Docket Page 11/11/2019 96 of 113 Page 2 of 2 SummaCare 1200 E Market St, Suite 400 SummaCare Akron, OH 44305-4018 summacare.com September 5, 2018 MSP Recovery, LLC 5000 SW 75 Ave, Suite 400 Miami, FL 33155 Re: Recovery Agreement This letter is in reference to that certain Recovery Agreement dated May 12, 2017 by and between SummaCare, Inc. and MSP Recovery, LLC. 18, 2016). Glaxo and Hoffman-La Roche's efforts were so successful that they catapulted Zantac into the position of most widely-prescribed drug in the world. All of Plaintiffs’ claims arise in part from conduct Defendants purposefully directed to Plaintiffs’ home state. Each member of the Enterprise benefited from the common purpose: the Defendants sold more Zantac than they would have otherwise had the NDMA contamination been known. ; pp. § 2-314; Mass. IN WITNESS WHEREOF, this Assignment is executed on the date set forth below and Assignor confirms that it is to be deemed effective, nunc pro tunc, on March 20, 2018. 3, pp. If agreed, parties should complete and file the Consent form found on our website. 191. Filing fees $ 400.00 receipt number 113C-12136965, filed by MSP Recovery Claims, Series LLC. Most recently, on October 18, 2019, Zantac's current manufacturer, Defendant Sanofi, issued a recall of its Zantac in the U.S. and Canada. 82 https://monographs.iarc.fr/wp-content/uploads/2019/07/Preamble-2019.pdf, at p. 35 (last accessed Nov. 11, 2019). The consent form is available under the forms section of our website. In 1983, another study was published, this one specifically relating to ranitidine. Ann. Liteplo, et al., Concise International Chemical Assessment Document 38: N-Nitrosodimethylamine, WORLD HEALTH ORGANIZATION (2002), available at https://www.who.int/ipcs/publications/cicad/en/cicad38.pdf. 2924 Document Document 1-6 Entered 13-3 Filed on FLSD 11/12/19 Docket Page 11/11/2019 103 of 113Page 4 of 11 Case 1:19-cv-24657-XXXX Case MDL No.

Defendants have engaged in unfair competition or unfair or deceptive acts or practices in violation of Alaska Stat. "61 57 Yong Dong Liu, et al., Formation Mechanism of NDMA from Ranitidine, Trimethylamine, and Other Tertiary Amines during Chloramination: A Computational Study, 48 ENVIRONMENTAL SCIENCE & TECHNOLOGY 8653 (June 26, 2014). 2/2/12 Emblem L.W. 2924 Document Document 1-3 Entered 13-3 Filed on FLSD 11/12/19 Docket Page 11/11/2019 92 of 113 Page 1 of 3 EXHIBIT C DocuSign Envelope ID: E08433A3-C6B4-4434-96BD-235072BCBB2F Case 1:19-cv-24657-XXXX Case MDL No. 95. Each Defendant expressly represented and warranted that their Zantac was safe in accordance with its new drug applications and FDA approvals. Formaldehyde is a known carcinogen.81 IARC classifies something as a known carcinogen when "there is sufficient evidence of carcinogenicity in humans.